Diagnostic Solutions Laboratory
Diagnostic Solutions Laboratory was founded to bridge the gap between healthcare providers and the clinical laboratory. Our commitment is to serve the clinical needs of the health care provider with cutting-edge laboratory medicine by utilizing proven methodologies that are accurate and reliable. By working with experienced clinicians and opinion leaders throughout multiple medical disciplines we are able to build assays that are clinically relevant and provide actionable results.
Since the introduction of the GI-MAP™ (GI Microbial Assay Plus) in 2015, Diagnostic Solutions Laboratory has established itself as the leader in quantitative PCR GI testing. With a commitment to research, and by using the latest in qPCR technology, we have experienced unparalleled growth while providing our practitioners with the most sensitive, specific and diagnostically relevant GI stool testing results available.
Now, Diagnostic Solutions Laboratory is once again at the forefront of laboratory science, bringing clinicians the latest revolutionary clinical assessment tool, the CytoDx™. With an assessment of 16 key serum cytokines, the CytoDx™ provides clinicians with powerful insight into their patient’s systemic immune regulatory function, allowing for advanced health assessment and individualized treatment plans based on specific immune responses.
In recent decades, it has become evident that the microbial communities that colonize the digestive tract impact health profoundly. Due to its relative inaccessibility, the small intestinal microbiome has been less well-studied than the microbiomes
… Read More
Join Betsy Redmond, Ph.D., MMSc, RDN, on June 15 at 2 PM ET as she explains how to use the OMX™ Organic Metabolomics profile to identify metabolic signatures associated with disease.
Metabolic signatures have been defined as a pattern of
… Read More
Aging is characterized by alterations in the various components of the intestinal barrier -- including microbial dysbiosis and a decline in epithelial regenerative capacity -- that result in reduced barrier function. This aging-related
… Read More
Join Betsy Redmond, PhD. MMSc, RD, on September 7 at 2 PM ET for an exciting webinar discussing the role metabolomic testing plays in evaluating gut health.
Metabolomics can help clinicians better identify areas of concern and reveal early
… Read More
Irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) are commonly-diagnosed conditions. Yet, it is often challenging for practitioners to help patients with these conditions to achieve satisfactory, long-term symptom
… Read More
Developments in Metabolomics: Dietary Insights & Impacts for Clinical Practice
Precision nutrition utilizes -omics techniques to personalize diets. Metabolomic testing plays a key role in clinical practice. It identifies current individual
… Read More
Functional gastrointestinal (GI) disorders such as irritable bowel syndrome and functional dyspepsia is thought to affect at least 15% of the general population. Mast cell activation and dysbiosis are among the leading pathophysiological processes that
Join us on September 17th at 3 PM ET, as Dr. Tom Fabian presents an exciting webinar about the role the microbiome plays in food sensitivities. Adverse food reactions - including food allergies, food sensitivities, and food intolerances - are among the
… Read MoreLatest Topics
SHARE